We are Sorry, This Page doesn't Exist
Orchard RX Announces Potential Pricing for IPO
Biopharmaceutical company Orchard RX is offering more than 13 million shares in an initial public offering valued up to more than $245 million......»»
Moderna Announces Potential Pricing for IPO
Transformative medicines company Moderna intends to price more than 21 million shares for an initial public offering valued up to $600 million......»»
Tencent Music Announces Potential Pricing in Massive IPO
Tencent Music Entertainment, the largest online music entertainment platform in China, expects to price 82 million American depositary shares for an initial public offering valued up to more than $1........»»
Legacy Housing Announces Potential Pricing for IPO
Legacy Housing intends to price 3.5 million shares for an initial public offering valued up to more than $51 million......»»
Rain Therapeutics announces anticipated milestones
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Autolus Therapeutics announces an additional publication for AUTO1
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hoth Therapeutics announces virtual exhibits on HT-KIT, HT-001
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
MindMed announces launch of collaboration with Nextage Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Protagonist Therapeutics announces first subject dose in phase 1 study of PN-232
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Seres Therapeutics announces presentation of Phase 3 Ecospor III study data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Larimar Therapeutics announces $95M private placement of common stock
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Seres Therapeutics announces David Arkowitz to join as EVP CFO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sorrento Therapeutics announces first patient treated in Enbrel study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
ADC Therapeutics announces three abstracts to be presented at ASCO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Allogene Therapeutics announces results from ALLO-501, ALLO-501A studies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Prime Therapeutics announces August return-to-work date
It will raise its capacity at the Eagan office building, known internally as Prime Landing, up to about 25% starting August 2......»»
Silence Therapeutics announces data from GEMINI Phase 1 study of SLN124
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioXcel Therapeutics announces FDA acceptance of NDA filing for BXCL501
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Altice USA Gets Downgrade From BofA: Here"s Why
Among U.S. cable operators, Altice USA Inc (NYSE: ATUS) is the most at risk from potential broadband pricing pressure, according to BofA Securities. Latest Ratings for A.....»»
Summit Therapeutics announces preclinical candidate SMT026738
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»